Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simona Jaafar

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Endocrinology and Metabolism Clinics of North America|October 23, 2025
Bone Health in AcromegalyMaria Francesca Birtolo, Simona Jaafar, Giacomo Cristofolini, et al.
Reviews in Endocrine & Metabolic Disorders|December 9, 2024
Nutritional status and gastroenteropancreatic neuroendocrine neoplasms: lights and shadows with a clinical guide from the NIKE GroupGiovanni Vitale, Germano Gaudenzi, Monica Oldani, et al.
Clinical Ophthalmology (Auckland, N.Z.)|October 21, 2025
GLP-1R Agonists Improve Ocular Surface Parameters in Type 2 Diabetes MellitusGiovanni Ottonelli, Alessandro Gaeta, Novella Montericcio, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|July 18, 2024
Late-onset Schmidt's Syndrome Presenting with Severe Hyponatremia: A Case ReportStella Pigni, Giacomo Cristofolini, Simona Jaafar, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|July 18, 2024
From Adenoma to Carcinoma: the Unexpected Evolution of an Apparently Stable Adrenal LesionGiacomo Cristofolini, Giulia Maida, Simona Jaafar, et al.
Endocrine|September 20, 2025
Safety of Romosozumab in women with cancer and osteoporosis at high risk of fracturesRoberto Colle, Alberto Piasentier, Alessandro Fanti, et al.
Reviews in Endocrine & Metabolic Disorders|April 2, 2025
Incretins and SGLT-2 inhibitors in diabetic patients with neuroendocrine tumors: current updates and future directionsRosaria M Ruggeri, Erika Maria Grossrubatscher, Eleonora Ciocca, et al.
Journal of Endocrinological Investigation|January 31, 2025
Early administration of romosozumab prevents rebound of bone resorption related to denosumab withdrawal in fractured post-menopausal women: a real-world prospective studyAlberto Piasentier, Alessandro Fanti, Maria Francesca Birtolo, et al.
Cancers|August 26, 2023
Urinary 5-Hydroxyindolacetic Acid Measurements in Patients with Neuroendocrine Tumor-Related Carcinoid Syndrome: State of the ArtRoberta Elisa Rossi, Elisabetta Lavezzi, Simona Jaafar, et al.
Endocrine-Related Cancer|September 8, 2025
Clinical presentation of bone metastases in neuroendocrine tumors: a retrospective cohort studyElisabetta Lavezzi, Simona Jaafar, Isabella Chiardi, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Endocrinology and Metabolism Clinics of North America|October 23, 2025
Bone Health in AcromegalyMaria Francesca Birtolo, Simona Jaafar, Giacomo Cristofolini, et al.
Reviews in Endocrine & Metabolic Disorders|December 9, 2024
Nutritional status and gastroenteropancreatic neuroendocrine neoplasms: lights and shadows with a clinical guide from the NIKE GroupGiovanni Vitale, Germano Gaudenzi, Monica Oldani, et al.
Clinical Ophthalmology (Auckland, N.Z.)|October 21, 2025
GLP-1R Agonists Improve Ocular Surface Parameters in Type 2 Diabetes MellitusGiovanni Ottonelli, Alessandro Gaeta, Novella Montericcio, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|July 18, 2024
Late-onset Schmidt's Syndrome Presenting with Severe Hyponatremia: A Case ReportStella Pigni, Giacomo Cristofolini, Simona Jaafar, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|July 18, 2024
From Adenoma to Carcinoma: the Unexpected Evolution of an Apparently Stable Adrenal LesionGiacomo Cristofolini, Giulia Maida, Simona Jaafar, et al.
Endocrine|September 20, 2025
Safety of Romosozumab in women with cancer and osteoporosis at high risk of fracturesRoberto Colle, Alberto Piasentier, Alessandro Fanti, et al.
Reviews in Endocrine & Metabolic Disorders|April 2, 2025
Incretins and SGLT-2 inhibitors in diabetic patients with neuroendocrine tumors: current updates and future directionsRosaria M Ruggeri, Erika Maria Grossrubatscher, Eleonora Ciocca, et al.
Journal of Endocrinological Investigation|January 31, 2025
Early administration of romosozumab prevents rebound of bone resorption related to denosumab withdrawal in fractured post-menopausal women: a real-world prospective studyAlberto Piasentier, Alessandro Fanti, Maria Francesca Birtolo, et al.
Cancers|August 26, 2023
Urinary 5-Hydroxyindolacetic Acid Measurements in Patients with Neuroendocrine Tumor-Related Carcinoid Syndrome: State of the ArtRoberta Elisa Rossi, Elisabetta Lavezzi, Simona Jaafar, et al.
Endocrine-Related Cancer|September 8, 2025
Clinical presentation of bone metastases in neuroendocrine tumors: a retrospective cohort studyElisabetta Lavezzi, Simona Jaafar, Isabella Chiardi, et al.
Pageof 2